About this role

Lead global HEOR/RWE strategy and evidence generation activities for the BTK degrader asset across product lifecycle, ensuring alignment with cross-functional objectives
Develop and execute integrated value evidence generation plan, including disease burden, treatment patterns, comparative effectiveness, indirect comparisons, economic modeling, and patient-centered outcomes to demonstrate clinical and economic value
Design and execute real-world evidence and comparative effectiveness studies using various real-world data sources including claims and electronic health records to support differentiation
Collaborate with cross-functional partners on JCA/HTA submissions and lead key HEOR deliverables timely including indirect comparisons and economic modeling
Lead development of Global Value Dossiers and US AMCP dossier to support reimbursement submissions and value communication
Drive scientific dissemination of HEOR/RWE evidence through abstracts, manuscripts, and congress presentations and omnichannel distributions

Advanced degree in Health Economics Outcomes Research (HEOR), Epidemiology, Public Health, Biostatistics, or related discipline
PhD with 5+ years or Master’s degree with 7+ years of related experience in biopharmaceutical industry or consulting
Hematology/Oncology experience strongly preferred
Proficiency in Microsoft Office, familiarity with statistical software, HEOR modeling tools and AI preferred

Director, Global Health Economic & Outcomes Research – HEOR/RWE Lead

Key skills